VBI Vaccines
VBIV
#10530
Rank
A$2.82 M
Marketcap
A$0.09834
Share price
0.00%
Change (1 day)
-89.74%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$15.27. In 2022 the company made an earnings per share (EPS) of A-$19.88 a decrease over its 2021 EPS that were of A-$12.20.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$19.8862.96%
2021A-$12.2028.57%
2020A-$9.49-54.35%
2019A-$20.78-52.58%
2018A-$43.8210.23%
2017A-$39.7614.29%
2016A-$34.79-62.8%
2015A-$93.5290.68%
2014A-$49.05-7.95%
2013A-$53.29-57.97%
2012A-$126.79-78%
2011A-$576.423151.47%
2010A-$17.7323.87%
2009A-$14.31-18.48%
2008A-$17.5612.08%
2007A-$15.67-49.47%
2006A-$31.00
2005N/A-100%
2004A-$13.7811.94%
2003A-$12.31-81.89%
2002A-$67.99196.44%
2001A-$22.9384.33%
2000A-$12.44-65.37%
1999A-$35.93-29.45%
1998A-$50.9229.61%
1997A-$39.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.43-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.52-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.53-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA